Gene · 79644
Papers377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The lithium-magnesium-zinc axis under stress: regulation of N-glycosylation-linked proteostasis and Alzheimer's disease. | Inflammopharmacology | 2026 | 42680959 | PubTator, text mining | PubMed |
| Novel blood lncRNA biomarkers associated with clinical severity and specific cognitive dimensions in Alzheimer's disease. | J Alzheimers Dis | 2026 | 42523149 | PubTator, text mining | PubMed |
| Tissue-specific expression and regulation of congenital disorders of glycosylation genes: A GTEx-based in silico study. | Mol Genet Metab Rep | 2026 | 42472049 | PubTator, text mining | PubMed |
| SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma. | Oncogene | 2026 | 42401760 | PubTator, text mining | PubMed |
| Endogenous oestrogens as neuroprotective modulators in the human retina: Evidence from transcriptomic profiling and aromatase inhibition. | J Neuroendocrinol | 2026 | 41877439 | PubTator, text mining | PubMed |
| Neuro-Ophthalmic Presentation of Steroid 5a-Reductase Type 3 Congenital Disorder of Glycosylation: A Case of Monozygotic Twins. | Cureus | 2026 | 41769439 | PubTator, text mining | PubMed |
| Extensive Hypoglycosylation of Serum N-Glycoproteins in SRD5A3 Deficiency. | J Inherit Metab Dis | 2026 | 41732066 | PubTator, text mining | PubMed |
| 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes. | NeuroSci | 2026 | 41718149 | PubTator, text mining | PubMed |
| Albumin as a glycoprotein biomarker in congenital disorders of glycosylation. | Mol Genet Metab | 2026 | 41713138 | PubTator, text mining | PubMed |
| Clinical, biochemical and genetic characterization of an Egyptian patient with SRD5A3-congenital glycosylation disorder. | Ophthalmic Genet | 2026 | 41667393 | PubTator, text mining | PubMed |
| Repurposing the HMG-CoA Reductase Inhibitor Atorvastatin for SRD5A3-CDG. | bioRxiv | 2026 | 41648237 | PubTator, text mining | PubMed |
| Genome-wide Mendelian randomization implicates metabolism-related gene expression in inflammatory bowel disease in European populations. | Rev Esp Enferm Dig | 2026 | 41569127 | PubTator, text mining | PubMed |
| HydraRNA: a hybrid architecture based full-length RNA language model. | Genome Biol | 2025 | 41214747 | PubTator, text mining | PubMed |
| Association of Germline Single Nucleotide Polymorphisms in Steroid Hormone Metabolism Pathway With Androgen Deprivation Therapy Prognosis of Prostate Cancer in Chinese Population. | Cancer Med | 2025 | 41176761 | PubTator, text mining | PubMed |
| Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model. | Discov Oncol | 2025 | 40835789 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals that RNA pseudouridylation-related gene NHP2 promotes the progression of uveal melanoma and validated in vivo and in vitro. | Exp Eye Res | 2025 | 40812391 | PubTator, text mining | PubMed |
| Predicting disease-overarching therapeutic approaches for congenital disorders of glycosylation using multi-OMICS. | Mol Genet Metab | 2025 | 40743674 | PubTator, text mining | PubMed |
| Predicting disease-overarching therapeutic approaches for Congenital Disorders of Glycosylation using multi-OMICS. | bioRxiv | 2025 | 40672295 | PubTator, text mining | PubMed |
| Machine learning identifies SRD5A3 as a propionate-related prognostic biomarker in triple-negative breast cancer. | Sci Rep | 2025 | 40442220 | PubTator, text mining | PubMed |
| High SRD5A3 expression is correlated with promotion of proliferation and inhibition of apoptosis in B-cell non-Hodgkin lymphoma and suggests a poor prognosis. | PLoS One | 2025 | 40397909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79644/papers